Conventional management of partial-thickness burn wounds includes the use of paraffin gauze dressing, frequently with topical silver-based antibacterial creams. Some creams form an overlying slough that renders wound assessment difficult and are painful upon application. An alternative to conventional management, moist exposed burn ointment (MEBO), has been proposed as a topical agent that may accelerate wound healing and have antibacterial and analgesic properties. One hundred fifteen patients with partial-thickness burns were randomly assigned to conventional (n ‫؍‬ 58) or MEBO treatment (n ‫؍‬ 57). A verbal numerical rating score of pain was made in the morning, after burn dressing, and some 8 hours later. Patient pain profiles were summarized by locally weighted regression smoothing technique curves and the difference between treatments estimated using multilevel regression techniques. Mean verbal numerical rating scale pain levels (cm) in week 1 for all patients were highest at 3.2 for the after dressing assessment, lowest in the evening at 2.6, and intermediate in the morning at 3.0. This pattern continued at similar levels in week 2 and then declined by a mean of 0.5 in all groups in week 3. There was little evidence to suggest a difference in pain levels by treatment group with the exception of the postdressing pain levels in the first week when those receiving MEBO had a mean level of 0.7 cm (95% confidence interval, 0.2 to 1.1) lower than those on conventional therapy. MEBO appeared to bring greater pain relief for the postdressing assessment during the first week after burns. This initial relief, together with comparable pain levels experienced on other occasions, indicates that MEBO could be an alternative to conventional burns management. (J Burn Care Rehabil 2003;24:289 -296)
Although the immediate healing of the burn wounds may be of primary concern to patients admitted to hospital with major burn injury, other aspects of the total care, like methods of resuscitation at admission, management of concomitant trauma, pain, and residual scarring are also of importance. Pain may be caused by the wound itself or may be related to procedures. 1 Different strategies are available to manage burn pain. These include pharmacotherapy, physical therapy, such as massage and electrical stimulation, and hypnosis. [2] [3] [4] Ang et al 5, 6 described the results of a randomized controlled trial comparing conventional treatment and moist exposed burn ointment (MEBO) in patients with partial-thickness burns. MEBO is an oilbased ointment containing sesame oil, ␤-sitosterol, berberine, and other small quantities of plant ingredients and is used in China for full-as well as partialthickness burns. 7 The trial concluded that MEBO achieved similar efficacy to conventional treatment with respect to wound healing, antibacterial properties and indicated marginal differences in reported pain levels but reduced hospital costs.
Ang et al 5 focused on the burn wound healing properties of the two treatments, and no detailed comparison of the longitudinal pain profiles over the whole period of hospital stay was made. Therefore, our objective was to contrast in detail the successive three daily pain levels recorded over a period of up to 21 days after admission.
MATERIAL AND METHODS
All admitted patients aged 6 to 80 years with partialthickness burns were eligible for the trial except those with chemical or electrical burns. The patient's consent was obtained after a full explanation was given of the treatment options and the manner of treatment allocation. The Singapore General Hospital Ethics Committee approved the protocol.
For conventional treatment (C), the burn wounds were cleansed with plain chlorhexidine 0.05% and deblistered where necessary. Superficial burns were treated with paraffin-impregnated gauze (Jelonet™ Tulle gras, Smith & Nephew, London, UK) or polyurethane dressing (Opsite™, Smith & Nephew, London, UK). Deeper burns were dressed with silver sulphadiazine cream and changed twice daily. With MEBO, the wounds were not débrided but cleansed with normal saline gauze if they were soiled. The wounds were then dabbed dry with sterile gauze. MEBO was smeared onto the wounds at 1 mm thickness at four hourly intervals with a sterile gloved finger, without removal in the first 5 days of therapy. On the sixth day, the accumulated residue was removed with a finely serrated metal spatula followed by a fresh application of MEBO. Wounds that were not suitable for exposed therapy alone were dressed with MEBO on Tulle gras twice daily. In both treatment groups, tangential excision, skin grafting, and surgery were performed as required. Patients were considered for discharge once 75% of the initial total burn area was healed. Analgesics (both opiates and nonopiates) were prescribed on an on-demand basis depending on patient-specific requirements. In addition, because of the emergency nature of the admissions, analgesia was offered in the period before consent was obtained during which vital resuscitation was taking place. Details of the above, as well as the justification of the number of patients required, are provided by Ang et al. 5 Pain was assessed using a verbal numerical rating scale similar to a visual analog scale. 8 The nurse explained, in an appropriate local language, how pain was to be assessed and indicated an analogy with: No pain, 0; slight pain, 1 to 2; mild pain, 3 to 4; moderate pain, 5; moderately severe pain, 6 to 9; and severe pain, 10. The patient was then asked for a numerical response from 0 to 10 (for convenience we refer to these responses as in cm). This verbal assessment was first made immediately after patient consent was obtained and before randomization.
Patients were randomized to C or MEBO either by telephone to the statistical office (office hours) or by sealed envelopes retained in the ward (other times). After randomization pain was assessed three times daily: once upon awakening, immediately after first dressing of the wound, and in the evening. These continued until the final dressing before discharge.
Graphical plots of pain with time for awakening, after dressing, and evening pain assessments by treatment group were summarized by a locally weighted regression smoothing technique with a bandwidth of 0.3 and a tri-cube weighting function. 9 The statistical model to test for treatment differences has to take account of correlation among repeated measures and group-specific changes over the whole 21-day period and distinguish the three periods (awakening, after dressing, and evening). It needs to accommodate observations that may be missing. The techniques described as generalized estimating equations allow such models to be constructed.
Models were chosen after first making visual examination of individual and treatment group patient profiles as well as tabulations. These considerations suggested a statistical model to describe the data of the type
Here, Pain jw is the pain score, which is assumed to have an approximately normal distribution, for a patient receiving treatment j (j ϭ 1 for C, j ϭ 2 for MEBO) in successive weeks w. [1] [2] [3] Each of the n patients provides repeated observations with which to estimate this model. In the above model, pain levels in week 1 correspond to w 2 ϭ w 3 ϭ 0, those in week 2 to w 2 ϭ 1, w 3 ϭ 0, and in week 3 to w 2 ϭ 0, w 3 ϭ 1. The parameters jw estimate the interactions between treatment and week (denoted M ϫ W in Tables 3 and 4) . That is, they provide a check as to whether or not the magnitude of the difference (if any) between MEBO and C remains the same from week to week. Although there are six possible combinations of treatment and week, when j ϭ 1, 11 ϭ 12 ϭ 13 ϭ 0, as does 21 ϭ 0. Hence, the parameters to estimate with the data are ␣, , 2 , 3 , 22 , and 23 . However, the main focus is to test the hypothesis corresponding to the effect of treatment, that is, to test that ϭ 0. In the situation, where the pain reported does not depend on either which treatment is given nor the week in which it is assessed, then , 2 , 3 , 22 , and 23. will be all zero. In this case, ␣ represents the mean pain level for all patients and this will be the same whatever treatment received or week assessed. Descriptions of these types of models are given by Brown et al 10 and Fayers and Machin. 11 The influence of the potential bias caused by missing observations was examined by hotdeck imputation. 12 All models were fitted using Stata computer software, 13 which also provides the corresponding standard errors and 95% confidence intervals.
RESULTS

Patient Characteristics
Between March 1, 1997, and October 24, 1998, 115 patients with partial-thickness burns were admitted to the trial through the Singapore National Burns Center. There were 58 patients randomized to C, but 1 was sedated for ventilation therapy and 57 to MEBO, although 1 was ineligible, 1 discharged immediately, and 1 withdrew consent. For these patients, no pain data were collected. Thus, the pain analysis takes into account information from 111 patients, and their characteristics are summarized in Table 1 The burns were caused by flames (50.5%), scalds from boiling water (37.8%), and scalds from hot oil (11.7%). No patient had major concomitant injuries. Figure 1 shows the locally weighted regression smoothing technique fit for each period by treatment group over the first 21 days after randomization (the individual data points are omitted for purposes of clarity). In general, the summary scores for the morning ( Figure 1A ) and the evening assessments ( Figure  1C) show a gradual rise until approximately day 10 (week 2) and thereafter a gradual decline and, although at similar levels for both treatment groups, marginally favoring C. However, for the postdressing assessment ( Figure 1B ) measurement, there is a gradual decline over the 3-week period with C but with lower levels reported with MEBO for the first week. Thereafter, the pattern is similar to the morning and evening assessments. Figure 1 suggests that separate models are needed for the morning, after dressing, and evening visual analog score pain assessments because there appears a varying difference between treatments in each of these periods and one that also changes differentially over time. The corresponding mean pain values by week and treatment group calculated for all the information available are summarized in Table 2 . These means are described as naïve estimates to distinguish them from those estimated by the modeling process (Table 5) .
Pain Profiles
Fitting the Model
The results of fitting the morning pain score models are summarized in Table 3 , where the estimate of each parameter and the corresponding standard error are given. Those estimates that are statistically significant are indicated. In Table 3 , successive models estimate the effect on the morning pain score of treatment, first taking no account of week or baseline pain scores (model I), then adding week (model II), and week by treatment interaction (model III). If an interaction is present, this corresponds to the effect size that is the pain difference (MEBO Ϫ C), changing in successive weeks. Finally, adjustment for the prerandomization pain levels recorded is added to the model (model IV).
The full modeling process of Table 3 (details not shown) was repeated for postdressing and evening pain assessments and each suggested that model III was required to summarize the results effectively. The regression coefficients for these are given in Table 4 , which also repeats those of morning pain scores of Table 3 to facilitate comparisons. Despite the prerandomization (baseline) pain score being important in determining subsequent levels of pain (the regression coefficient ␤ is statistically significant in Table 3 ), its presence in the models only marginally effects the estimated treatment effects summarized in Table 5 . In these models, the estimates of for morning and evening pain assessments are small, (morning ϭ 0.050 cm, evening ϭ 0.059 cm). In contrast, for the postdressing scores ϭ Ϫ0.657cm and indicates a statistically significant reduction in pain (P ϭ .005) with MEBO.
However, it is important to take account of the week because average pain levels are down by Ϫ0.569 and Ϫ1.143 cm in weeks 2 and 3 with C, but these are offset by a rise of 0.806 and 0.765, respectively, with MEBO.
The models also provide estimates of the mean values in each treatment by week group. To illustrate how these are calculated, we use the evening MEBO in week 3 estimate obtained from Table 4 .
From Table 4 , the estimates are ␣ ϭ 2.579, ϭ 0.059, 3 ϭ Ϫ0.459, and 23 ϭ Ϫ0.239. Thus, the evening mean pain level for MEBO in week 3 is estimated as 2.579 ϩ 0.059 Ϫ 0.459 Ϫ 0.239 ϭ 1.940 cm. The difference between this and the corresponding value of 2.120 cm for C is Ϫ0.180 cm with 95% confidence interval for is Ϫ0.909 to 0.549. These correspond to the entries in bold type in Table 5 (and Table 2 ). Table 5 also includes the corresponding estimates and associated 95% confidence intervals for the other pain assessments. It can be seen from Tables 2 and 5 that the naïve and modeled-based estimates can differ.
Although (70.3%) patients were given analgesia in the early stages after admission, this was before randomization and so did not affect the randomization process. The median length of time from first analgesia to prerandomization pain assessment was approximately 2 hours (range, 20 to 300 minutes). An additional analysis, adjusting for whether or not analgesia was given before randomization, had little impact on the values reported in Table 5 (details not shown).
On occasions, some pain assessments were not taken. This included situations in which the assessment had been overlooked (rarely) but more importantly those that could not have been recorded as the patient had been discharged before day 21 on the basis of the clinical progress of his wounds. Finally, repeating all the analyses with hotdeck imputation to assess the impact of these missing values gave results very similar to those in Table 4 and hence Table 5 . In addition, the treatment differences that are reported in Table 5 remain little changed when adjusted for the patient-specific characteristics of age, sex, type of burn, or BSA.
DISCUSSION
Although the approach to burn care management is relatively standard in many parts of the world, in
China an alternative method that includes MEBO is becoming widespread. However, before the report by Ang et al 5 in patients with partial-thickness burns, there was no evidence for the relative efficacy from randomized, controlled trials. As is common in many situations, the randomized trial did not confirm the extent of the claimed benefits of MEBO with respect to healing properties that had been made from nonrandomized studies. 7 Nevertheless, the trial was strongly suggestive that the healing and infection rates obtained from MEBO were comparable with those of a more conventional approach. This trial also Table 5 . Estimated mean verbal numerical rating score pain levels (cm) for successive weeks and corresponding estimated differences between treatments given by model III of suggested that "MEBO imparts a greater analgesic effect . . . especially in the first 5 days following injury." However, that conclusion was based on a graphic examination of the average pain profiles of the morning, after dressing, and afternoon mean pain levels over the first 14 days after injury. Our aim was to use the full data profile and to quantify any observed benefit using a statistical modeling approach.
There is no doubt that the modeling process introduces more complexity into the analysis of the data. However, this is unavoidable because the data themselves are complex since they consist of thrice-daily pain assessments starting at the time of randomization and continuing until the (varying) day of discharge. This implies, for example, that there are fewer observations made at day 21 than day 7 because (hopefully) many patients will have been discharged by the latter time. Thus, graphic comparisons at this time ( Figure 5 in Ang et al) 6 will not be so reliable. To add further complexity, the successive patient observations are correlated and, of particular importance, there are some missing data. The modeling approach attempts to ensure that by looking at the whole patient experience and checking the robustness of conclusions, a reliable comparison between the treatments is made.
In our situation, the differences between MEBO and C were small in magnitude and the estimates of relative efficacy provided by the naïve estimates of Table 2 and those of Table 5 differed little in magnitude. Nevertheless, the estimates provided by the models are less likely to be biased and the corresponding confidence intervals more reliable. For example, the 95% confidence interval for the evening assessment of week 3 in Table 2 (estimate ϩ0.121 cm: indicating less pain with C) is Ϫ0.297 to 0.540 cm. In contrast that corresponding to the same comparison in Table 5 (estimate Ϫ0.180 cm: now indicating less pain with MEBO) is from Ϫ0.909 to 0.549 cm and is wider. In general, this will usually be the case because the latter calculations make full use of the correlation between successive observations on the same patient. In addition, the hotdeck imputation provides us with additional reassurance that the "missing" observations do not distort the estimates of Table 5 to any degree (details not shown). This is possibly because the mean length hospital stay of 16.7 and 17.6 days for patients receiving C and MEBO was very similar It should be stressed that there is considerable variation both between different patients and within the same patient over time. In fact, pain scores include the extremes of 0 and 10 cm virtually at all stages of the trial and for both treatment groups. Thus, the estimated mean differences of Table 5 should be placed in this context. In addition, analgesics (opiates and nonopiates) were prescribed on an on-demand basis depending on patient-specific requirements and these no doubt reduced the overall levels of pain. There is little evidence of differential use between C and MEBO patients 6 so that the difference in pain levels between treatments should not be unduly affected here. However, the levels of pain recorded with an overall average of approximately 3 cm (Figure 1 ) is much lower than the value of 6.5 cm suggested by Choinière et al for similar circumstances. 7 We recognize that there may be drawbacks to measuring pain using a verbal numerical rating scale. In addition, verbal assessment by the attending nurse inquiring of the patient poses further difficulties. However, in the context of patients with emergency burn injuries speaking a multiplicity of languages and dialects while at the same time undertaking a trial of alternative methods of patient management, it is difficult to see how other more refined methods could be practical. Clearly, the pain assessment methodology could have been modified as the patient progresses, but any change would then pose difficulties with interpretation.
In an ideal randomized clinical trial, patients, medical staff, and those who assess response are blind to the procedures being compared. In the patients of this trial such "blinding" is not possible in any of these respects. Thus, any observed advantage or disadvantage with MEBO must be placed within this less-than-optimal context. The analysis establishes that overall there is little difference in efficacy between MEBO and conventional therapy with respect to mean pain levels 6 and hence also refutes earlier claims of substantial benefits in this respect. 7 However, the modeling process confirms the reduction in first week after dressing pain levels by the use of MEBO and estimates this as 0.7 cm (95% confidence interval, 0.2 to 1.1). The analgesic effect is attributable to the presence of the layer of oily ointment that shields the burn wound from the external environment, whereas patients in C had dressings changed with washing before day 5.
CONCLUSION
In summary this randomized trial, although not confirming the substantial claims of non-randomized studies, has demonstrated that MEBO is similar in effectiveness to conventional treatment for patients with partial thickness burns. Thus, as Ang et suggest, it offers a practical alternative since it is cheap, can be stored in large quantities, is easily applied and hence its use may be advantageous in mass casualty situa-
